Compare · CELZ vs COIN
CELZ vs COIN
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Coinbase Global Inc. (COIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and COIN operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- COIN is the larger of the two at $42.70B, about 5324.7x CELZ ($8.0M).
- COIN has hit the wire 17 times in the past 4 weeks while CELZ has been quiet.
- COIN has more recent analyst coverage (25 ratings vs 1 for CELZ).
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Coinbase Global Inc.
Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy. The company provides primary financial account for the cryptoeconomy, a platform to invest, store, spend, earn, and use crypto assets; an online marketplace for hedge funds, money managers, and corporations; and a platform with technology and services to developers, merchants, and asset issuers that enables them to build applications that leverage crypto protocols. It serves retail users, institutions, and ecosystem partners. The company was founded in 2012 and is based in Wilmington, Delaware.
Latest CELZ
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
- Amendment: SEC Form 10-K/A filed by Creative Medical Technology Holdings Inc.
- SEC Form 10-K filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
Latest COIN
- Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.54 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
- Robert W. Baird reiterated coverage on Coinbase Global with a new price target
- Better and Coinbase Celebrate the First Token-backed Mortgage Fund Backed by Fannie Mae, Announce Official Product Launch Date
- Director Wilson Frederick R sold $1,815,364 worth of shares (10,000 units at $181.54) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Coinbase Global Inc.
- Chief Legal Officer Grewal Paul sold $346,683 worth of shares (1,960 units at $176.88) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 84,753 units (SEC Form 4)
- Chief People Officer Brock Lawrence J sold $1,250,483 worth of shares (6,616 units at $189.01) as part of a pre-agreed trading plan, decreasing direct ownership by 93% to 517 units (SEC Form 4)
- Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.39 Million Tokens, and Total Crypto and Total Cash Holdings of $12.3 Billion
- Chief Accounting Officer Jones Jennifer N. converted options into 4,564 shares and covered exercise/tax liability with 2,513 shares (SEC Form 4) to satisfy withholding tax
- Chief People Officer Brock Lawrence J converted options into 11,700 shares and covered exercise/tax liability with 5,084 shares, increasing direct ownership by 1,280% to 7,133 units (SEC Form 4) to satisfy withholding tax